![](/images/graphics-bg.png)
Hyperchloremic Metabolic Acidosis due to Cholestyramine: A Case Report and Literature Review
Joint Authors
McQuillan, Rory
Kamar, Fareed B.
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-09-03
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Cholestyramine is a bile acid sequestrant that has been used in the treatment of hypercholesterolemia, pruritus due to elevated bile acid levels, and diarrhea due to bile acid malabsorption.
This medication can rarely cause hyperchloremic nonanion gap metabolic acidosis, a complication featured in this report of an adult male with concomitant acute kidney injury.
This case emphasizes the caution that must be taken in prescribing cholestyramine to patients who may also be volume depleted, in renal failure, or taking spironolactone.
American Psychological Association (APA)
Kamar, Fareed B.& McQuillan, Rory. 2015. Hyperchloremic Metabolic Acidosis due to Cholestyramine: A Case Report and Literature Review. Case Reports in Nephrology،Vol. 2015, no. 2015, pp.1-3.
https://search.emarefa.net/detail/BIM-1058957
Modern Language Association (MLA)
Kamar, Fareed B.& McQuillan, Rory. Hyperchloremic Metabolic Acidosis due to Cholestyramine: A Case Report and Literature Review. Case Reports in Nephrology No. 2015 (2015), pp.1-3.
https://search.emarefa.net/detail/BIM-1058957
American Medical Association (AMA)
Kamar, Fareed B.& McQuillan, Rory. Hyperchloremic Metabolic Acidosis due to Cholestyramine: A Case Report and Literature Review. Case Reports in Nephrology. 2015. Vol. 2015, no. 2015, pp.1-3.
https://search.emarefa.net/detail/BIM-1058957
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1058957